Aboz Pharmaceuticals

Developer of targeted radiotherapy for cancer treatment

placeShanghai, Shanghai, China calendar_todayFounded 2021 groups1 employees language ablazepharma.com

Registered entities

Investor mix

8 investors on record; lead investors include Vivo Capital, Advantech Capital.

Investor typeCountShare
Venture capital788%
Private equity113%
Coming soon